These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32691913)

  • 21. Lewy bodies of Parkinson's disease. Immune electron microscopic demonstration of neurofilament antigens in constituent filaments.
    Pappolla MA
    Arch Pathol Lab Med; 1986 Dec; 110(12):1160-3. PubMed ID: 3022672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofilament as a biomarker - are we there yet?
    Hemingway C
    Eur J Paediatr Neurol; 2023 Jul; 45():A5. PubMed ID: 37423817
    [No Abstract]   [Full Text] [Related]  

  • 23. Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease.
    Gai WP; Vickers JC; Blumbergs PC; Blessing WW
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1039-46. PubMed ID: 7916375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis.
    Soelberg Sorensen P; Sellebjerg F
    Mult Scler; 2016 Aug; 22(9):1112-3. PubMed ID: 27364323
    [No Abstract]   [Full Text] [Related]  

  • 25. Neurofilaments in health and disease.
    Julien JP; Mushynski WE
    Prog Nucleic Acid Res Mol Biol; 1998; 61():1-23. PubMed ID: 9752717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to Hyun J.W. et al. "Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis".
    Akgün K; Ziemssen T
    Mult Scler; 2020 May; 26(6):742-743. PubMed ID: 31144585
    [No Abstract]   [Full Text] [Related]  

  • 27. Author Response: Exosomal Neurofilament Light: A Prognostic Biomarker for Remote Symptoms After Mild Traumatic Brain Injury?
    Kenney K; Guedes VA; Gill JM
    Neurology; 2021 Apr; 96(15):726. PubMed ID: 33846171
    [No Abstract]   [Full Text] [Related]  

  • 28. Reader Response: Exosomal Neurofilament Light: A Prognostic Biomarker for Remote Symptoms After Mild Traumatic Brain Injury?
    Kawada T
    Neurology; 2021 Apr; 96(15):725-726. PubMed ID: 33846170
    [No Abstract]   [Full Text] [Related]  

  • 29. Cerebrospinal fluid neurofilament light chain as a biomarker of neurodegeneration in the Tg4510 and MitoPark mouse models.
    Clement A; Mitchelmore C; Andersson DR; Asuni AA
    Neuroscience; 2017 Jun; 354():101-109. PubMed ID: 28461218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurofilament light chain - new potential for prediction and prognosis.
    Fyfe I
    Nat Rev Neurol; 2019 Oct; 15(10):557. PubMed ID: 31506590
    [No Abstract]   [Full Text] [Related]  

  • 31. Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.
    Farotti L; Paciotti S; Tasegian A; Eusebi P; Parnetti L
    Expert Rev Mol Diagn; 2017 Aug; 17(8):771-780. PubMed ID: 28604235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofilament makes light of MS treatment monitoring.
    Fyfe I
    Nat Rev Neurol; 2019 Apr; 15(4):188. PubMed ID: 30804512
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
    Siller N; Kuhle J; Muthuraman M; Barro C; Uphaus T; Groppa S; Kappos L; Zipp F; Bittner S
    Mult Scler; 2019 Apr; 25(5):678-686. PubMed ID: 29542376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies.
    Hill WD; Lee VM; Hurtig HI; Murray JM; Trojanowski JQ
    J Comp Neurol; 1991 Jul; 309(1):150-60. PubMed ID: 1716646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid biomarker for Parkinson's disease: An overview.
    Maass F; Schulz I; Lingor P; Mollenhauer B; Bähr M
    Mol Cell Neurosci; 2019 Jun; 97():60-66. PubMed ID: 30543858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The multifaceted role of neurofilament light chain protein: emerging opportunities in primary psychiatric conditions.
    Bavato F; Seifritz E; Quednow BB
    Brain; 2024 Jan; 147(1):e5-e6. PubMed ID: 37615305
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF and blood biomarkers for Parkinson's disease.
    Parnetti L; Gaetani L; Eusebi P; Paciotti S; Hansson O; El-Agnaf O; Mollenhauer B; Blennow K; Calabresi P
    Lancet Neurol; 2019 Jun; 18(6):573-586. PubMed ID: 30981640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipase D1 downregulation by α-synuclein: Implications for neurodegeneration in Parkinson's disease.
    Conde MA; Alza NP; Iglesias González PA; Scodelaro Bilbao PG; Sánchez Campos S; Uranga RM; Salvador GA
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):639-650. PubMed ID: 29571767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood neurofilament light chain at the doorstep of clinical application.
    Leppert D; Kuhle J
    Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e599. PubMed ID: 31516914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.